Anaveon, an immuno-oncology company, today announced that it has appointed Dr Allison Jeynes-Ellis to its Board of Directors.
read more
Press Releases
Anaveon, a New Immuno-Oncology Company, Announces CHF 35 million Series A Financing
Anaveon, an immuno-oncology company, today announced completion of a CHF 35 million Series A financing led by Syncona Ltd and joined by the Novartis Venture Fund.
read more